I agree that this site is using cookies. You can find further informations here.
X
Rizzieri, David A
362  results:
Search for persons X
?
1

Treatment of patients with blastic plasmacytoid dendritic c..:

Pemmaraju, Naveen ; Madanat, Yazan F. ; Rizzieri, David...
Leukemia & Lymphoma.  65 (2024)  5 - p. 548-559 , 2024
Link: https://doi.org/10.1080/..
 
?
2

Use of tamibarotene, a potent and selective RARα agonist, i..:

Stein, Eytan M. ; de Botton, Stephane ; Cluzeau, Thomas...
Leukemia & Lymphoma.  64 (2023)  12 - p. 1992-2001 , 2023
Link: https://doi.org/10.1080/..
 
?
3

Targeting RARA overexpression with tamibarotene, a potent a..:

de Botton, Stéphane ; Cluzeau, Thomas ; Vigil, Carlos...
Blood Advances.  7 (2023)  9 - p. 1858-1870 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Expert consensus on microtransplant for acute myeloid leuke..:

Ai, Huisheng ; Chao, Nelson J. ; Rizzieri, David A....
Heliyon.  9 (2023)  4 - p. e14924 , 2023
Link: https://doi.org/10.1016/..
 
?
5

A Phase I Trial of SYK Inhibition with Fostamatinib in the ..:

Lin, Chenyu ; DiCioccio, Rachel A. ; Haykal, Tarek...
Transplantation and Cellular Therapy.  29 (2023)  3 - p. 179.e1-179.e10 , 2023
Link: https://doi.org/10.1016/..
 
?
6

PB1773: AML AND MDS WITH RARA OVEREXPRESSION: MOLECULAR AND..:

Botton, Stéphane de ; Cluzeau, Thomas ; Vigil, Carlos...
HemaSphere.  7 (2023)  S3 - p. e50253dc , 2023
Link: https://doi.org/10.1097/..
 
?
7

Single-cell landscape analysis unravels molecular programmi..:

Poe, Jonathan C. ; Fang, Jiyuan ; Zhang, Dadong...
JCI Insight.  8 (2023)  11 - p. , 2023
Link: https://doi.org/10.1172/..
 
?
8

A simple prognostic system in patients with myelofibrosis u..:

Tamari, Roni ; McLornan, Donal P. ; Ahn, Kwang Woo...
Blood Advances.  7 (2023)  15 - p. 3993-4002 , 2023
Link: https://doi.org/10.1182/..
 
?
9

POSTER: AML-303 Tagraxofusp, an Anti-CD123 Therapy, in Pati..:

Pemmaraju, Naveen ; Konopleva, Marina ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S159 , 2023
Link: https://doi.org/10.1016/..
 
?
10

AML-303 Tagraxofusp, an Anti-CD123 Therapy, in Patients Wit..:

Pemmaraju, Naveen ; Konopleva, Marina ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S288 , 2023
Link: https://doi.org/10.1016/..
 
?
11

AML-465 Tagraxofusp, an Anti-CD123 Therapy, in Patients Wit..:

Pemmaraju, Naveen ; Konopleva, Marina ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S254 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Impact of Venetoclax and Azacitidine in Treatment-Naïve Pat..:

Pollyea, Daniel A. ; DiNardo, Courtney D. ; Arellano, Martha L....
Clinical Cancer Research.  28 (2022)  13 - p. 2753-2761 , 2022
Link: https://doi.org/10.1158/..
 
?
13

AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-..:

Pammaraju, Naveen ; Kantarjian, Hagop ; Sweet, Kendra...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S246-S247 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Revisiting a single day salvage conditioning following graf..:

Katsanis, Emmanuel ; Hennig, Therese ; Robinson, Jacob E....
Bone Marrow Transplantation.  57 (2022)  12 - p. 1845-1847 , 2022
Link: https://doi.org/10.1038/..
 
?
15

Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HS..:

Lin, Chenyu ; Morrison, Laura ; Alyea, Edwin P...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S250-S251 , 2022
Link: https://doi.org/10.1016/..
 
1-15